Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice

Brain metastases (BM) are frequently detected during the follow-up of patients with malignant tumors, particularly in those with advanced disease. Despite a major progress in systemic anti-cancer treatments, the average overall survival of these patients remains limited (6 months from diagnosis). Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Corroyer-Dulmont, Aurélien, Jaudet, Cyril, Frelin, Anne-Marie, Fantin, Jade, Weyts, Kathleen, Vallis, Katherine A., Falzone, Nadia, Sibson, Nicola R., Chérel, Michel, Kraeber-Bodéré, Françoise, Batalla, Alain, Bardet, Stéphane, Bernaudin, Myriam, Valable, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423367/
https://www.ncbi.nlm.nih.gov/pubmed/34504791
http://dx.doi.org/10.3389/fonc.2021.714514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423367/
https://www.ncbi.nlm.nih.gov/pubmed/34504791
http://dx.doi.org/10.3389/fonc.2021.714514

Ejemplares similares